Julie A Foster, MD | |
275 Route 30 N, Castleton Family Health Center, Bomoseen, VT 05732-9647 | |
(802) 468-5641 | |
(802) 468-2923 |
Full Name | Julie A Foster |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 25 Years |
Location | 275 Route 30 N, Bomoseen, Vermont |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215957295 | NPI | - | NPPES |
03599846 | Medicaid | NY | |
P00311030 | Other | VT | RR MEDICARE |
OVN3821 | Medicaid | VT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 0420011010 (Vermont) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bayada Home Health Care | Williston, VT | Home health agency |
Vna & Hospice Of The Southwest Region Inc | Rutland, VT | Home health agency |
Bayada Hospice | Norwich, VT | Hospice |
Rutland Regional Medical Center | Rutland, VT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Community Health Centers Of The Rutland Region Inc | 2961467386 | 85 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced that the Biologics License Application for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration.
"Chile launched a hepatitis and tetanus vaccination campaign Friday and doctors warned of outbreaks of diarrhea and infection among thousands of people displaced by the earthquake and the tsunami that heavily damaged or destroyed 36 hospitals and made garbage dumps of coastal towns and cities," the Associated Press reports. So far, no dysentery outbreaks or other communicable diseases had been reported, Chile's health ministry said, adding that it believed it had adequate amounts of tetanus and hepatitis vaccinations.
Once the heart is fully formed, the cells that make up heart muscle, known as cardiomyocytes, have very limited ability to reproduce themselves. After a heart attack, cardiomyocytes die off; unable to make new ones, the heart instead forms scar tissue. Over time, this can set people up for heart failure.
PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 1 days ago
Entity Name | Community Health Centers Of The Rutland Region Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336193838 PECOS PAC ID: 2961467386 Enrollment ID: O20041129000357 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced that the Biologics License Application for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration.
"Chile launched a hepatitis and tetanus vaccination campaign Friday and doctors warned of outbreaks of diarrhea and infection among thousands of people displaced by the earthquake and the tsunami that heavily damaged or destroyed 36 hospitals and made garbage dumps of coastal towns and cities," the Associated Press reports. So far, no dysentery outbreaks or other communicable diseases had been reported, Chile's health ministry said, adding that it believed it had adequate amounts of tetanus and hepatitis vaccinations.
Once the heart is fully formed, the cells that make up heart muscle, known as cardiomyocytes, have very limited ability to reproduce themselves. After a heart attack, cardiomyocytes die off; unable to make new ones, the heart instead forms scar tissue. Over time, this can set people up for heart failure.
PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 1 days ago
Entity Name | Community Health Centers Of The Rutland Region Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073567590 PECOS PAC ID: 2961467386 Enrollment ID: O20041129000784 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced that the Biologics License Application for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration.
"Chile launched a hepatitis and tetanus vaccination campaign Friday and doctors warned of outbreaks of diarrhea and infection among thousands of people displaced by the earthquake and the tsunami that heavily damaged or destroyed 36 hospitals and made garbage dumps of coastal towns and cities," the Associated Press reports. So far, no dysentery outbreaks or other communicable diseases had been reported, Chile's health ministry said, adding that it believed it had adequate amounts of tetanus and hepatitis vaccinations.
Once the heart is fully formed, the cells that make up heart muscle, known as cardiomyocytes, have very limited ability to reproduce themselves. After a heart attack, cardiomyocytes die off; unable to make new ones, the heart instead forms scar tissue. Over time, this can set people up for heart failure.
PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 1 days ago
Entity Name | Community Health Centers Of The Rutland Region Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104870922 PECOS PAC ID: 2961467386 Enrollment ID: O20050131001023 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced that the Biologics License Application for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration.
"Chile launched a hepatitis and tetanus vaccination campaign Friday and doctors warned of outbreaks of diarrhea and infection among thousands of people displaced by the earthquake and the tsunami that heavily damaged or destroyed 36 hospitals and made garbage dumps of coastal towns and cities," the Associated Press reports. So far, no dysentery outbreaks or other communicable diseases had been reported, Chile's health ministry said, adding that it believed it had adequate amounts of tetanus and hepatitis vaccinations.
Once the heart is fully formed, the cells that make up heart muscle, known as cardiomyocytes, have very limited ability to reproduce themselves. After a heart attack, cardiomyocytes die off; unable to make new ones, the heart instead forms scar tissue. Over time, this can set people up for heart failure.
PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 1 days ago
Entity Name | Community Health Centers Of The Rutland Region Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467681114 PECOS PAC ID: 2961467386 Enrollment ID: O20100804000784 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced that the Biologics License Application for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration.
"Chile launched a hepatitis and tetanus vaccination campaign Friday and doctors warned of outbreaks of diarrhea and infection among thousands of people displaced by the earthquake and the tsunami that heavily damaged or destroyed 36 hospitals and made garbage dumps of coastal towns and cities," the Associated Press reports. So far, no dysentery outbreaks or other communicable diseases had been reported, Chile's health ministry said, adding that it believed it had adequate amounts of tetanus and hepatitis vaccinations.
Once the heart is fully formed, the cells that make up heart muscle, known as cardiomyocytes, have very limited ability to reproduce themselves. After a heart attack, cardiomyocytes die off; unable to make new ones, the heart instead forms scar tissue. Over time, this can set people up for heart failure.
PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 1 days ago
Entity Name | Community Health Centers Of The Rutland Region Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780969345 PECOS PAC ID: 2961467386 Enrollment ID: O20120321000420 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced that the Biologics License Application for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration.
"Chile launched a hepatitis and tetanus vaccination campaign Friday and doctors warned of outbreaks of diarrhea and infection among thousands of people displaced by the earthquake and the tsunami that heavily damaged or destroyed 36 hospitals and made garbage dumps of coastal towns and cities," the Associated Press reports. So far, no dysentery outbreaks or other communicable diseases had been reported, Chile's health ministry said, adding that it believed it had adequate amounts of tetanus and hepatitis vaccinations.
Once the heart is fully formed, the cells that make up heart muscle, known as cardiomyocytes, have very limited ability to reproduce themselves. After a heart attack, cardiomyocytes die off; unable to make new ones, the heart instead forms scar tissue. Over time, this can set people up for heart failure.
PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Julie A Foster, MD 71 Allen St, Ste 403, Rutland, VT 05701-4570 Ph: (802) 772-4414 | Julie A Foster, MD 275 Route 30 N, Castleton Family Health Center, Bomoseen, VT 05732-9647 Ph: (802) 468-5641 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced that the Biologics License Application for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration.
"Chile launched a hepatitis and tetanus vaccination campaign Friday and doctors warned of outbreaks of diarrhea and infection among thousands of people displaced by the earthquake and the tsunami that heavily damaged or destroyed 36 hospitals and made garbage dumps of coastal towns and cities," the Associated Press reports. So far, no dysentery outbreaks or other communicable diseases had been reported, Chile's health ministry said, adding that it believed it had adequate amounts of tetanus and hepatitis vaccinations.
Once the heart is fully formed, the cells that make up heart muscle, known as cardiomyocytes, have very limited ability to reproduce themselves. After a heart attack, cardiomyocytes die off; unable to make new ones, the heart instead forms scar tissue. Over time, this can set people up for heart failure.
PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 1 days ago
Sarah Hart Dwyer, APRN Family Medicine Medicare: Medicare Enrolled Practice Location: 275 Route 30 N, Bomoseen, VT 05732 Phone: 802-468-5641 | |
Stephen Marion Rosmus, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 275 Route 30 N, Castleton Family Health Center, Bomoseen, VT 05732 Phone: 802-468-5641 Fax: 802-468-2923 | |
Jennifer Day Hanson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Route 30 N, Bomoseen, VT 05732 Phone: 802-773-3386 | |
Hans Peter Diercksen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Route 30 N, Bomoseen, VT 05732 Phone: 802-468-5641 Fax: 802-468-2923 | |
Bradley Alan Berryhill, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Route 30 N, Castleton Family Health Center, Bomoseen, VT 05732 Phone: 802-468-5641 Fax: 802-468-2923 | |
Dr. Stephen S Kornbluth, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Route 30 N, Bomoseen, VT 05732 Phone: 802-468-5641 Fax: 802-468-2923 |